Intervention Effect of Yizhi Baduanjin on Patients With Mild Cognitive Impairment
Condition(s):Mild Cognitive ImpairmentLast Updated:June 12, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Mild Cognitive ImpairmentLast Updated:June 12, 2023Not yet recruiting
Condition(s):Breast CancerLast Updated:May 17, 2023Completed
Condition(s):Postoperative Cognitive DysfunctionLast Updated:March 10, 2022Completed
Condition(s):Postoperative Cognitive Dysfunction; Mild Cognitive ImpairmentLast Updated:March 17, 2016Completed
Condition(s):Post Operative Cognitive DysfunctionLast Updated:September 10, 2019Completed
Condition(s):Cognitive Decline; Cognitive Impairment; Cognitive DeteriorationLast Updated:August 5, 2019Terminated
Condition(s):Cognitive Decline; Life Style; Risk ReductionLast Updated:January 12, 2024Active, not recruiting
Condition(s):Cognitive ImpairmentLast Updated:April 7, 2023Completed
Condition(s):Cognitive ImpairmentsLast Updated:October 18, 2022Completed
Condition(s):Postoperative Cognitive DysfunctionLast Updated:May 10, 2016Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.